Skip to content

SPP closes at 5pm AWST Wed 25th Nov 2026  Learn more    

Proteomics and Dimerix partner to improve the treatment of kidney disease

Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ), a leader in providing predictive diagnostics, is pleased to announce that it has partnered with innovative drug developer Dimerix Limited (ASX:DXB) to improve the treatment of chronic kidney disease (CKD).

Media Release